JP2015532923A5 - - Google Patents

Download PDF

Info

Publication number
JP2015532923A5
JP2015532923A5 JP2015533048A JP2015533048A JP2015532923A5 JP 2015532923 A5 JP2015532923 A5 JP 2015532923A5 JP 2015533048 A JP2015533048 A JP 2015533048A JP 2015533048 A JP2015533048 A JP 2015533048A JP 2015532923 A5 JP2015532923 A5 JP 2015532923A5
Authority
JP
Japan
Prior art keywords
composition
tissue
antibiotic
ecm
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015533048A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015532923A (ja
Filing date
Publication date
Priority claimed from US13/573,569 external-priority patent/US9072816B2/en
Application filed filed Critical
Publication of JP2015532923A publication Critical patent/JP2015532923A/ja
Publication of JP2015532923A5 publication Critical patent/JP2015532923A5/ja
Pending legal-status Critical Current

Links

JP2015533048A 2012-09-24 2013-06-15 生体組織の治療のための方法及びシステム Pending JP2015532923A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/573,569 2012-09-24
US13/573,569 US9072816B2 (en) 2006-01-18 2012-09-24 Composition for modulating inflammation of cardiovascular tissue
PCT/US2013/046039 WO2014046752A1 (en) 2012-09-24 2013-06-15 Method and system for treatment of biological tissue

Publications (2)

Publication Number Publication Date
JP2015532923A JP2015532923A (ja) 2015-11-16
JP2015532923A5 true JP2015532923A5 (enExample) 2016-07-28

Family

ID=50342519

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015533045A Pending JP2015532922A (ja) 2012-09-24 2013-05-29 生体組織の治療のための方法及びシステム
JP2015533049A Pending JP2015531664A (ja) 2012-09-24 2013-06-14 生体組織の治療のための方法及びシステム
JP2015533048A Pending JP2015532923A (ja) 2012-09-24 2013-06-15 生体組織の治療のための方法及びシステム

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2015533045A Pending JP2015532922A (ja) 2012-09-24 2013-05-29 生体組織の治療のための方法及びシステム
JP2015533049A Pending JP2015531664A (ja) 2012-09-24 2013-06-14 生体組織の治療のための方法及びシステム

Country Status (11)

Country Link
US (3) US9072816B2 (enExample)
EP (3) EP2887948A4 (enExample)
JP (3) JP2015532922A (enExample)
CN (1) CN104703614A (enExample)
AU (3) AU2013318632A1 (enExample)
BR (2) BR112014031796A2 (enExample)
CA (3) CA2875302A1 (enExample)
IL (2) IL236021A0 (enExample)
IN (1) IN2015DN01780A (enExample)
SG (2) SG11201408808WA (enExample)
WO (3) WO2014046744A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220023503A9 (en) 2007-05-10 2022-01-27 Aziyo Med, Llc Extracellular Matrix Tissue Prostheses
US20080279833A1 (en) 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US9283302B2 (en) 2011-12-16 2016-03-15 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
ES2553762T3 (es) * 2009-02-18 2015-12-11 Cormatrix Cardiovascular, Inc. Composiciones y métodos para prevenir la arritmia cardiaca
EP2598181B1 (en) 2010-07-31 2021-04-21 Cook Medical Technologies LLC Collagenous tissue pocket for an implantable medical device, and manufacturing method therefor
CN107206084B (zh) * 2014-11-10 2021-05-14 伊井正明 用于增强干细胞功能的内含抑制素纳米粒子制剂以及含有其的功能增强干细胞及其制备方法
US20160143720A1 (en) * 2014-11-26 2016-05-26 Cormatrix Cardiovascular, Inc. Mesh Fiber Members and Methods for Forming and Using Same for Treating Damaged Biological Tissue
US20160143738A1 (en) * 2014-11-26 2016-05-26 Cormatrix Cardiovascular, Inc. Biological Constructs for Treating Damaged Organs and Tissue
WO2016093863A1 (en) * 2014-12-10 2016-06-16 Cormatrix Cardiovascular, Inc. Method and system for treatment of damaged biological tissue
EP3302594B1 (en) * 2015-06-03 2024-09-11 Wisconsin Alumni Research Foundation Cardiac fibroblast-derived extracellular matrix and injectable formulations thereof for treatment of ischemic disease or injury
US11331348B2 (en) 2016-04-28 2022-05-17 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions comprising extracellular matrix of primitive animal species and related methods
CA3010717A1 (en) 2016-07-11 2018-01-18 Cormatrix Cardiovascular, Inc. Prosthetic tissue valves
KR101710615B1 (ko) * 2016-09-07 2017-02-27 주식회사 파마리서치프로덕트 생착률을 증가시킨 이식용 진피층 및 이의 제조 방법
WO2019241910A1 (zh) * 2018-06-19 2019-12-26 中国医学科学院阜外医院 基于药物预处理的间充质干细胞来源外泌体的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US6485723B1 (en) * 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
CA2267449C (en) * 1996-11-05 2008-10-14 Purdue Research Foundation Myocardial graft constructs
US6375989B1 (en) * 1996-12-10 2002-04-23 Purdue Research Foundation Submucosa extracts
CA2274033C (en) * 1996-12-10 2010-05-11 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
IL139708A0 (en) * 2000-11-15 2002-02-10 Amiel Gilad Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
WO2003007790A2 (en) * 2001-07-16 2003-01-30 Depuy Products, Inc. Hybrid biologic/synthetic porous extracellular matrix scaffolds
US20040078090A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
WO2004110427A1 (en) * 2003-06-18 2004-12-23 Institut De Cardiologie De Montréal /Montréal Heart Institute Preventing atrial fibrillation (af) with the use of statin drugs
AU2004253508A1 (en) * 2003-06-25 2005-01-13 Acell, Inc. Conditioned matrix compositions for tissue restoration
FI20045223L (fi) * 2004-06-15 2005-12-16 Bioretec Oy Monitoiminen biohajoava komposiitti ja kirurginen implantti, joka käsittää mainitun komposiitin
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
AU2004270239C1 (en) * 2003-09-04 2011-07-07 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
WO2006102063A2 (en) * 2005-03-19 2006-09-28 Cook Biotech Incorporated Prosthetic implants including ecm composite material
US20060293760A1 (en) * 2005-06-24 2006-12-28 Dedeyne Patrick G Soft tissue implants with improved interfaces
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
US9532943B2 (en) * 2010-12-20 2017-01-03 Cormatrix Cardiovascular, Inc. Drug eluting patch for the treatment of localized tissue disease or defect
WO2008021127A2 (en) * 2006-08-08 2008-02-21 Howmedica Osteonics Corp. Expandable cartilage implant
US8361503B2 (en) * 2007-03-02 2013-01-29 University of Pittsburgh—of the Commonwealth System of Higher Education Extracellular matrix-derived gels and related methods
WO2009086483A2 (en) * 2007-12-26 2009-07-09 Gel-Del Technologies, Inc. Biocompatible protein particles, particle devices and methods thereof
WO2009086499A2 (en) 2007-12-28 2009-07-09 Cook Biotech Incorporated Medical composition including an extracellular matrix particulate
JP2010059235A (ja) * 2008-09-01 2010-03-18 Fujifilm Corp 紫外線吸収剤組成物
ES2628100T3 (es) * 2008-09-30 2017-08-01 The Regents Of The University Of California Composiciones que comprenden matriz extracelular descelularizada obtenida a partir de tejido cardíaco
ES2553762T3 (es) 2009-02-18 2015-12-11 Cormatrix Cardiovascular, Inc. Composiciones y métodos para prevenir la arritmia cardiaca

Similar Documents

Publication Publication Date Title
JP2015532923A5 (enExample)
JP2011256183A5 (enExample)
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
CL2014000468A1 (es) Compuestos derivados del acido 2-oxo-6-(fenil/heteroaril)l-1,2-dihidropiridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para el alivio de una infeccion bacteriana.
WO2015024010A3 (en) Substituted hydroxamic acid compounds
BR112013015796A2 (pt) composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, método de preparar um quelante 18f-nota, e, composição farmacêutica.
CL2012003722A1 (es) Compuestos derivados del acido naf-2-ilacetico; composicion farmaceutica; y uso para el tratamiento del sida.
WO2013122888A3 (en) Methods of treating bacterial infections
BR112014030649A2 (pt) inibidores macrocíclicos da flaviviridae vírus
EP2662353A3 (en) Antibacterial agents
BR112013015010A2 (pt) produto, substrato, composição farmacêutica, uso de um produto, e, método para tratar uma infecção microbiana
ZA201105290B (en) Antibiotic compositions for the treatment of gram negative infections
EP2953624A4 (en) METHOD FOR THE TREATMENT OF MICROBIAL INFECTIONS, INCLUDING MASTITIS
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
EP2217211A4 (en) ORAL ABSORBENT SOLID DOSAGE FORMULATION FOR VANCOMYCIN
CL2014001154A1 (es) Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana.
CL2014001861A1 (es) Compuestos derivados de bencil sulfonamida, inhibidores de mogat-2; compuesto cristalino; composicion farmaceutica; y su uso en el tratamiento de la hipertrigliceridemia.
DOP2010000373A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
CL2008000110A1 (es) Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos.
BR112013015798A2 (pt) composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, e, composição farmacêutica
EP3150631C0 (en) PASSIVE ANTI-GLUCOSAMINIDASE IMMUNIZATION FOR STAPHYLOCOCCUS AUREUS INFECTIONS
HK1210825A1 (en) Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
LT3820856T (lt) C-manozido junginiai, naudingi šlapimo takų infekcijoms gydyti
MX2017003011A (es) Metodo para usar derivado de acido hidroxamico novedoso y sustancia antibacterial en combinacion.